Clinical Trial Update: Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the anti-platelet effects of berberine in patients with coronary artery disease after percutaneous coronary intervention …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Berberine (berberine)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Coronary Artery Disease, Percutaneous Coronary Intervention | Phase 4 | Status: RECRUITING